US panel endorses Roche's Actemra for rheumatoid arthritis
This article was originally published in Scrip
Executive Summary
A US FDAadvisory panel has overwhelmingly endorsed Roche's novel monoclonal antibody Actemra (tocilizumab) for rheumatoid arthritis.